Premium

The psychedelic revolution is coming. Psychiatry may never be the same

Andrew Jacobs
New York Times·
13 mins to read
The psychedelic revolution is coming. Psychiatry may never be the same
A dose of psilocybin, at the Center for Psychedelic and Consciousness Research at Johns Hopkins. Photo / Matt Roth, The New York Times

Psilocybin and MDMA are poised to be the hottest new therapeutics since Prozac. Universities want in, and so does Wall Street. Some worry a push to loosen access could bring unintended consequences.

It's been a long, strange trip in the four decades since Rick Doblin, a pioneering psychedelics researcher, dropped

Save